Related Experiment Video
Updated: Mar 29, 2026

Development of Compendium for Esophageal Squamous Cell Carcinoma
Published on: April 12, 2024
Comparison of clinicopathologic features and survival between eastern and western population with esophageal squamous
Jie Zhang1, Yizhou Jiang1, Chunxiao Wu1
11 Department of Oncology, Fudan University Shanghai Medical College, Shanghai 200032, China ; 2 Department of Thoracic Surgery, Fudan University Shanghai Cancer Center, Shanghai 200032, China ; 3 Department of Cancer Control & Prevention, Shanghai Municipal Center for Disease Control & Prevention, Shanghai 200336, China ; 4 Department of Thoracic Surgery, Shanghai Chest Hospital, Shanghai Jiaotong University, Shanghai 200032, China ; 5 Department of Radiotherapy, Fudan University Shanghai Cancer Center, Shanghai 200032, China ; 6 Department of Cardiothoracic Surgery, University of Pittsburgh Medical Center, Pittsburgh 15213, USA.
Background:
Esophageal squamous cell carcinoma (ESCC) is the major histologic subtype of esophageal cancer, characterized by a high mortality rate and geographic differences in incidences. It is unknown whether there is difference between "eastern" ESCC and "western" ESCC. This study is attempted to demonstrate the hypothesis by comparing ESCC between Chinese residents and Caucasians living in the US.
Methods:
The data sources of this study are from United States SEER limited-use database and Shanghai Cancer Registries by Shanghai Municipal Center for Disease Control (SMCDC). Consecutive, non-selected patients with pathologically diagnosed ESCC, between January 1, 2002 and December 31, 2006, were included in this analysis. 1-year, 3-year and 5-year survival estimates were computed and compared between two populations. A Cox proportional hazards model was used to determine factors affecting survival differences.
Results:
A total of 1,718 Chinese, 1,624 Caucasians ESCC patients with individual American Joint Commission on Cancer (AJCC) staging information were included in this study. The Caucasian group had a significantly higher proportion of female patients than Chinese (38.24% vs. 18.68% P<0.01). ESCC was diagnosed in Chinese patients at an earlier age and stage than Caucasians. Generally, Chinese patients had similar overall survival rate with Caucasian by both univariate and multivariate analysis. Overall survival was significantly worse only in male Caucasians compared to Chinese patients (median survival time, 12.4 vs. 14.5 months, P<0.01, respectively).
Conclusions:
ESCC from eastern and western countries might have some different features. These differences need to be taken into account for the management of ESCC patients in different ethnic groups.
More Related Videos
Related Concept Videos
Comparing the Survival Analysis of Two or More Groups
Cancer Survival Analysis

